the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-65
SponsorFayoum University
About this trial
Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18-65 years
smoke ≥5 cigarettes per day
motivated to quit smoking,
have access to a smartphone or computer
Disqualifiers
Pregnant women
individuals with severe psychiatric conditions
those already using other smoking cessation therapies.
Trial design
Design model
Parallel
Treatments tested in this trial
AI Molar Mind
Other interventiona baseline oral health assessment using AI Molar Mind, which analyzes intraoral images and self-reported oral health data.
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: AI Molar Mind GroupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
smoking cessation indicator
Biochemically verified smoking cessation at 6 months (measured by exhaled carbon monoxide levels \<6 ppm).
Time frame
base line, 6-month post smoking cessationLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
faculty of Dentistry, Fayoum UniversityRecruiting21523, Fayoum, Alexandria Governorate
Egypt
EgyptSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov